Casma Therapeutics

Developer of therapies for treating rare genetic disorders

placeCambridge, Massachusetts, United States calendar_todayFounded 2017 groups38 employees language casmatx.com

Registered entities

Social engagement

Social engagement: 5.7K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

14 investors on record; lead investors include The Column Group, Eventide Funds, Schroders Capital, Third Rock Ventures.

Investor typeCountShare
Venture capital429%
Private equity214%
Angel & family office17%
Bank & private debt17%
Other / undisclosed643%

Recent activity

7 Apr 2026
Event
American Academy of Neurology 2026 Annual Meeting
Coming soon